Angiogenesis in the development of head and neck cancer and its inhibition by chemopreventive agents

Critical Reviews in Oral Biology and Medicine

Volumn 10, Issue 2, 1999, Pages 153-164

  Lingen, M W ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Chemoprevention; Oral cancer

Indexed keywords

ALPHA INTERFERON; ANGIOGENESIS INHIBITOR; BATIMASTAT; CM 101; FUMAGILLOL CHLOROACETYLCARBAMATE; INTERLEUKIN 12; ISOTRETINOIN; MARIMASTAT; OCTREOTIDE; PENTOSAN POLYSULFATE; RETINOID; ROQUINIMEX; SURAMIN; TECOGALAN; THALIDOMIDE; THROMBOCYTE FACTOR 4;

ANGIOGENESIS; ARTICLE; BLOOD DISEASE; CANCER INHIBITION; CAPILLARY HEMANGIOMA; CHEILITIS; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONJUNCTIVITIS; DRUG INHIBITION; DRY SKIN; FLU LIKE SYNDROME; HEAD AND NECK CANCER; HUMAN; HYPERTRIGLYCERIDEMIA; LEUKOPLAKIA; PRECANCER; PRIORITY JOURNAL; SOLID TUMOR; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH;

EID: 0032838841     PISSN: 10454411     EISSN: None     Source Type: Journal    
DOI: 10.1177/10454411990100020301     Document Type: Article

References (145)

1. Alcalde RE, Shintani S, Yoshihama Y, Matsumura T (1995). Cell proliferation and tumor angiogenesis in oral squamous cell carcinoma. Anticancer Res 15:1417-1422.
2. Alcalde RE, Terakado N, Otsuki K, Matsumura T (1997). Angiogenesis and expression of platelet-derived endothelial cell growth factor in oral squamous cell carcinoma. Oncology 54:324-328.
3. Amos B, Lotan R (1990). Retinoid-sensitive cells and cell lines. Meth Enzymol 190:217-225.
4. Arensman RM, Stolar CH (1979). Vitamin A effect on tumor angiogenesis. J Pediatr Surg 14:809-813.
5. Arnold F, West DC (1991). Angiogenesis in wound healing. Pharmacol Ther 52:407-422.
6. Bouck N (1992). Angiogenesis: a mechanism by which oncogenes and tumor suppressor genes regulate tumorigenesis. Cancer Treatment Res 63:359-371.
7. Bouck N, Stellmach V, Hsu H (1995). How tumors become angiogenic. Adv Cancer Res 69:135-174.
8. Boring CC, Squire TS, Tong T, Montgomery S (1994). Cancer statistics. CA Cancer J Clin 44:7-26.
9. Boylan JF, Jackson J, Steiner MR, Shih TY, Duigou GJ, Roszman T, et al. (1990). Role of Ha-ras oncogene in mediating progression of the tumor cell phenotype. Anticancer Res 10:717-724.
10. Bron L, Monnier P (1995). Molecular alterations in head and neck squamous cell carcinoma. Clin Otolaryngol 20:291-298.
11. Brouty-Boye D, Zetter BR (1980). Inhibition of cell motility by interferon. Science 208:516-518.
12. Brown LF, Harrist TJ, Yeo KT, Stahle-Backdahl M, Jackman RW, Berse B, et al. (1995). Increased expression of VEGF in bullous pemphigoid, dermatitis herpetiformis, and erythema multiforme. J Invest Dermatol 104:744-749.
13. Burge-Bottenbley A, Shklar G (1983). Retardation of experimental oral cancer development by retinyl acetate. Nutr Cancer 5:121-129.
14. Carrau RL, Barnes EL, Snyderman CH, Petruzzelli G, Kachman K, Rueger R, et al. (1995). Tumor angiogenesis as a predictor of tumor agressiveness and metastatic potential in squamous cell carcinoma of the head and neck. Invasion & Metastasis 15:197-202.
15. Castelli C, Sensi M, Lupetti R, Mortarini R, Panceri P, Anichini A, et al. (1994). Expression of IL-1α, IL-6, and tumor necrosis factor alpha in human melanoma clones is associated with that of mutated N-ras oncogene. Cancer Res 54:4785-4790.
16. Chen LL, Narayanan R, Hibbs MS, Benn PA, Clawson ML, Lu G, et al. (1993). Altered epidermal growth factor signal transduction in activated Ha-ras transformed human keratinocytes. Biochem Biophys Res Commun 193:167-174.
17. Clark WH (1991). Tumor progression and the nature of cancer. Br J Cancer 64:631-644.
18. Cohen RF, Contrino J, Spiro JD, Mann EA, Chen LL, Kreutzer DL (1995). Interleukin-8 expression by head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 121:202-209.
19. Dameron KM, Volpert OV, Tainsky MA, Bouck N (1994a). Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265:1582-1584.
20. Dameron KM, Volpert OV, Tainsky MA, Bouck N (1994b). The p53 tumor suppressor gene inhibits angiogenesis by stimulating the production of thrombospondin. Cold Spring Harbor, NY: Symposia in Quantitative Biology, Vol. LVIX, pp. 1-7.
21. Day GL, Blot WJ (1992). Second primary tumors in patients with oral cancer. Cancer 70:14-19.
22. Delli-Bovi P, Curatola AM, Newman KM, Sato Y, Moscatelli D, Hewick RM, et al. (1988). Processing, secretion, and biological properties of a novel growth factor of the fibroblast growth factor family with oncogenic potential. Mol Cell Biol 8:2933-2941.
23. Demetri GD, Ernst TJ, Pratt ES, Zenzie BW, Rheinwald JG, Griffin JD (1990). Expression of ras oncogenes in cultured human cells alters the transcriptional and post-transcriptional regulation of cytokine genes. J Clin Invest 86:1261-1269.
24. Denhart BC, Guidi AJ, Tognazzi K, Dvorak HF, Brown LF (1997). Vascular permeability factor/vascular endothelial growth factor and its receptors in oral and laryngeal squamous cell carcinoma and dysplasia. Lab Invest 77:659-664.
25. Dray TG, Hardin NJ, Sofferman RA (1995). Angiogenesis as a prognostic marker in early head and neck cancer. Ann Otol Rhinol Laryngol 104:724-729.
26. Ezekowitz RA, Mulliken JB, Folkman J (1992). Interferon alpha-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med 326:1456-1463.
27. Fearon ER, Vogelstein B (1990). A genetic model for colorectal tumorigenesis. Cell 61:759-767.
28. Field JK (1995). The role of oncogenes and tumor suppressor genes in the etiology of oral, head and neck squamous cell carcinoma. J R Soc Med 88:35-39.
29. Folkman J (1995). Tumor angiogenesis. The molecular basis of cancer. Mendelsohn J, Howley PM, Israel MA, Liotta LA, editors. Philadelphia: W.B. Saunders, pp. 206-232.
30. Folkman J, Hannahan D (1991). Switch to the angiogenic phenotype during tumorigenesis. Princess Takamatsu Symposia 22:339-347.
31. Folkman J, Szabo S, Stovroff M, McNeil P, Li W, Shing Y (1991). Duodenal ulcer. Discovery of a new mechanism and development of angigenic therapy that accelerates healing. Ann Surg 214:414-425.
32. Forough R, Xi Z, MacPhee M, Friedman S, Engleka KA, Sayers T, et al. (1993). Differential transforming abilities of non-secreted and secreted forms of fibroblast growth factor-1. J Biol Chem 268:2960-2968.
33. Frank S, Hubner G, Breier G, Longaker MT, Greenhalgh DG, Werner S (1995). Regulation of vascular endothelial cell growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem 270:12607-12613.
34. Friesel R, Komoriya A, Maciag T (1987). Inhibition of endothelial cell proliferation by gamma-interferon. J Cell Biol 104:689-696.
35. Gallo RL, Grabbe S, Choi SS, Bleicher P, Granstein RD (1992). Cyclosporin increases granulocyte/ macrophage colony-stimulating factor (GM-CSF) activity and gene expression in murine keratinocytes. J Invest Dermatol 98:274-278.
36. Game SM, Stone A, Scully C, Prime SS (1990). Tumor progression in experimental oral carcinogenesis is associated with changes in EGF and TGF-B receptor expression and altered responses to these growth factors. Carcinogenesis 11:965-973.
37. Garbisa S, Pozzatti R, Muschel RJ, Saffiotti U, Ballin M, Goldfarb RH, et al. (1987). Secretion of type IV collagenolytic protease and metastatic phenotype: induction by transfection with c-Ha-ras but not c-Harasplus Ad2-E1a. Cancer Res 47:1523-1528.
38. Gasparini G, Presta M (1996). Clinical studies with angiogenesis inhibitors: biological rationale and challenges for their evaluation. Ann Oncol 7:441-444.
39. Gleich LL, Biddinger PW, Pavelic ZP, Gluckman JL (1996a). Tumor angiogenesis in T1 oral cavity squamous cell carcinoma: role in predicting tumor aggressiveness. Head & Neck 18:343-346.
40. Gleich LL, Srivastava L, Gluckman JL (1996b). Plasma platelet-derived growth factor: preliminary study of a potential marker in head and neck cancer. Ann Otol Rhinol Laryngol 105:710-712.
41. Click AB, Sporn MB, Yuspa SH (1991). Altered expression of TGF-beta and TGF-alpha in primary keratinocytes and papillomas expressing v-Ha-ras. Mol Carcinogen 4:210-219.
42. Goldfarb M, Deed R, MacAllan D, Walther W, Dickson C, Peters G (1991). Cell transformation by Int-2: a member of the fibroblast growth factor family. Oncogene 6:65-71.
43. Good DJ, Polverini PJ, Rastinejad F, Le Beau MM, Lemon RS, Frazier WA, et al. (1990). A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci USA 87:6624-6628.
44. Gradishar WJ (1997). An overview of clinical trials involving inhibitors of angiogenesis and their mechanism of action. Invest New Drugs 15:49-59.
45. Grandis JR, Tweardy DJ (1993a). TGF-alpha and EGFR in head and neck cancer. J Cell Biochem 17:188-191.
46. Grandis JR, Tweardy DJ (1993b). Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res 53:3579-3584.
47. Grandis JR, Zeng Q, Tweardy DJ (1996). Retinoic acid normalizes the increased gene transcription rate of TGF-alpha and EGFR in head and neck cancer cell lines. Nature Med 2:237-240.
48. Holmgren L, O'Reilly MS, Folkman J (1995). Dormancy of micrometastases-balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med 1:149-153.
49. Hong KW, Endicott J, Itri LM, Doos W, Batsakis JG, Bell R, et al. (1986). 13-cis-retinoic acid in the treatment of oral leukoplakia. N Engl J Med 315:1501-1505.
50. Hong KW, Lippman SM, Itri LM, Karp DD, Lee JS, Byers RM, et al. (1990). Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck. N Engl J Med 323:795-801.
51. Hori A, Sadada R, Masutani E, Naito K, Sakura Y, Fujita T, et al. (1991). Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human fibroblast growth factor. Cancer Res 51:6180-6184.
52. Hsu SC, Volpert OV, Steck PA, Mikkelsen T, Polverini PJ, Rao S, et al. (1996). Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1. Cancer Res 56:5684-5691.
53. Iberg N, Rogelj S, Fanning P, Klagsburn M (1989). Purification of 18- and 22-kDa forms of basic fibroblast growth factor from rat cells transformed by the ras oncogene. J Biol Chem 264:19951-19955.
54. Ingber D, Folkman J (1989). Inhibition of angiogenesis through modulation of collagen metabolism. Lab Invest 59:44-51.
55. Inoue K, Ozeki Y, Suganuma T, Sugiura Y, Tanaka S (1997). Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma. Association with angiogenesis and tumor progression. Cancer 79:206-213.
56. Jankun J, Maher VM, McCormick JJ (1991). Malignant transformation of human fibroblasts correlates with increased activity of receptor-bound plasminogen activator. Cancer Res 51:1221-1226.
57. Janot F, Elnaggar AK, Morrison RS, Liu TJ, Taylor DL, Clayman GL (1995). Expression of basic fibroblast growth factor in squamous cell carcinoma of the head and neck is associated with degree of histologic differentiation. Int J Cancer 64:117-123.
58. Jones GJ, Itri L (1986). Safety and tolerance of recombinant interferon alpha-2a in cancer patients. Cancer 57:1709-1715.
59. Kasid A, Lippman ME (1987). Estrogen and oncogene mediated growth regulation of human breast cancer cells. J Steroid Biochem 27:1-3.
60. Kelloff GJ, Boone CW, Steele VE, Crowell JA, Lubet R, Sigman CC (1994). Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials. Cancer Res 54:2015-2024.
61. Kelloff GJ, Hawk ET, Karp JE, Crowell JA, Boone CW, Steele VE, et al. (1997). Progress in clinical chemoprevention. Semin Oncol 24:241-252.
62. Kendall RL, Wang G, Thomas KA (1996). Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem Biophys Res Commun 226:324-328.
63. Kim DJ, Li B, Winer J, Armanini M, Gillet N, Phillips HS, et al. (1993). Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor cell growth in vivo. Nature 362:841-844.
64. Klijanienko J, El-Naggar AK, Braud F, Rodriguez-Peralto J-L, Rodrigues R, Itzhaki M, et al. (1995). Tumor vascularization, mitotic index, histopathologic grade, and DNA ploidy in the assessment of 114 head and neck squamous cell carcinomas. Cancer 75:1649-1656.
65. Kratz G, Haegerstrand A, Dalsgaard CJ (1991). Conditioned medium from cultured human keratinocytes has growth stimulatory properties on different human cell types. J Invest Dermatol 97:1039-1043.
66. Leedy DA, Trune DR, Kronz JD, Weidner N, Cohen JI (1994). Tumor angiogenesis, the p53 antigen, and cervical metastasis in squamous carcinoma of the tongue. Otolaryngol Head Neck Surg 111:417-422.
67. Liaudet-Coopman EDE, Berchem GJ, Wellstein A (1997). In vivo inhibition of angiogenesis and induction of apoptosis by retinoic acid in squamous cell carcinoma. Clin Cancer Res 3:179-184.
68. Lingen MW, Polverini PJ, Bouck NP (1996a). Retinoic acid induces cells cultured from oral squamous cell carcinomas to become anti-angiogenic. Am J Pathol 149:247-258.
69. Lingen MW, Polverini PJ, Bouck NP (1996b). Inhibition of squamous cell carcinoma angiogenesis by direct interaction of retinoic acid with endothelial cells. Lab Invest 74:476-483.
70. Lingen MW, DiPietro LP, Solt DB, Bouck NP, Polverini PJ (1997). The angiogenic switch in hamster buccal pouch keratinocytes is dependent on TFGβ-1 and is unaffected by ras activation. Carcinogenesis 18:329-338.
71. Lippman SM, Hong WK (1989). Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with early-stage disease. Int J Radiat Oncol Biol Phys 17:691-694.
72. Lippman SM, Benner SE, Hong WK (1993a). Chemoprevention: strategies for the control of cancer. Cancer 72:984-990.
73. Lippman SM, Glisson BS, Kavanagh JJ, Lotan R, Hong WK, Paredes-Espinoza M, et al. (1993b). Retinoic acid and interferon combination studies in human cancer. Eur J Cancer 29(A):9-13.
74. Lippman SM, Benner SE, Hong WK (1994). Cancer chemoprevention. J Clin Oncol 12:851-873.
75. Lotan R, Lotan D, Sacks PG (1990). Inhibition of tumor cell growth by retinoids. Meth Enzymol 190:100-110.
76. Maheshwari RK, Srikantan V, Bhartiya D, Kleinman HK, Grant DS (1990). Differential effects of interferon gamma and alpha on in vitro model of angiogenesis. J Cell Physiol 146:164-169.
77. Majewski S, Szmurlo A, Marczak M, Jablonska S, Bollag W (1993). Inhibition of tumor cell-induced angiogenesis by retinoids, 1,25-dihydroxyvitamin D3 and their combinations. Cancer Lett 75:35-39.
78. Majkewski S, Szmurlo A, Marczak M, Jablonska S, Bollag W (1994). Synergistic effect of retinoids and interferon alpha on tumor-induced angiogenesis: anti-angiogenic effect on hpv-harboring tumor-cell lines. Int J Cancer 57:81-85.
79. Majewski S, Marczak M, Szmurlo A, Jablonska S, Bollag W (1995). Retinoids, interferon alpha, 1,25-dihydroxyvitamin D3 and their combination inhibit angiogenesis induced by non-hpv-harboring tumor cell lines. RAR alpha mediates the antiangiogenic effects of retinoids. Cancer Lett 89:117-124.
80. Mann EA, Hibbs MS, Spiro JD, Bowik C, Wang XZ, Clawson M, et al. (1995). Cytokine regulation of gelatinase production by head and neck squamous cell carcinoma: the role of tumor necrosis factor-alpha. Ann Otol Rhinol Laryngol 104:203-209.
81. Marshall CJ, Vousden K, Ozzanne B (1985). The involvement of activated ras genes in determining the transformed phenotype. Proc R Soc London 226:99-106.
82. Matsumoto K, Kakamura T, Kramer RH (1994). Hepatocyte growth factor induces tyrosine phosphorylation of focal adhesion kinase and promotes migration and invasion by oral squamous cell carcinoma cells. J Biol Chem 269:31807-31813.
83. Matsuo K, Ishibashi Y, Kobayashi I, Ozeki S, Ohishi M, Tange T, et al. (1994). New human oral squamous cell carcinoma cell line and its tumorigenic subline produce granulocyte colony-stimulating factor. Jpn J Cancer Res 85:1257-1262.
84. Mikami Y, Tsukuda M, Ito K, Arai Y, Ito T (1996). Peritumoral angiogenesis in carcinomas of the head and neck. Auri Nasus Larynx 23:57-62.
85. Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A (1994). Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 367:576-578.
86. Moriyama M, Kumagai S, Kawashiri K, Kojima K, Kakihara K, Yamamoto E (1997). Immunohistochemical study of tumour angiogenesis in oral squamous cell carcinoma. Oral Oncol 33:369-374.
87. Moore DM, Kalvakolanu DV, Lippman SM, Kavanagh JJ, Hong WK, Borden EC, et al. (1994). Retinoic acid and interferon in human cancer: mechanistic and clinical studies. Sem Hematol 31:31-37.
88. Moroco JR, Solt DB, Polverini PI (1990). Sequential loss of suppressor genes for three specific functions during in vivo carcinogenesis. Lab Invest 63:298-306.
89. Myoken Y, Myoken Y, Okamoto T, Sato JD, Takada K (1994). Immunohistochemical localization of fibroblast growth factor-1 (FGF-1) and FGF-2 in oral squamous cell carcinoma. J Oral Pathol 23:451-456.
90. Neely EK, Morhenn VB, Hintz RL, Wilson DM, Rosenfeld RG (1991). Insulin-like growth factors are mitogenic for human keratinocytes and a squamous cell carcinoma. J Invest Dermatol 96:104-110.
91. Nickoloff BJ, Mitra RS, Varani J, Dixit VM, Polverini PJ (1994). Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis. Am J Pathol 144:820-828.
92. Oikawa T, Hirotani K, Nakamura O, Shudo K, Hiragun A, Iwahuchi T (1989). A highly potent antiangiogenic activity of retinoids. Cancer Lett 48:157-162.
93. Okada K, Shimizu Y, Taytuskishiro T, Minemura M, Nishimori H, Higuchi K, et al. (1994). Serum interleukin-8 levels in patients with hepatocellular carcinoma. Int Hepat Commun 2:178-182.
94. Oliveira IC, Sciavolino PJ, Lee TH, Vilcek J (1992). Downregulation of interleukin 8 gene expression in human fibroblasts: unique mechanism of transcriptional inhibition by interferon. Proc Natl Acad Sci 89:9049-9053.
95. Oliveira IC, Mukaida M, Matushima K, Vilcek J (1994). Transcriptional inhibition of the IL-8 gene by interferon is mediated by the NF-κB site. Mol Cell Biol 14:5300-5308.
96. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, et al. (1995). Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79:315-328.
97. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, et al. (1997). Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88:277-285.
98. Owasianowski M, Busch FW, Bonnekoh B, Orfanos CE (1991). Long-term cultured adult keratinocytes secrete granulocyte-macrophage colony-stimulating factor but not interleukin-3 after cytokine exposure in vitro. Skin Pharmacol 4:158-164.
99. Parangi S, Dietrich W, Christofori G, Lander ES, Hanahan D (1995). Tumor suppressor loci on mouse chromosomes 9 and 16 are lost at distinct stages of tumori-genesis in a transgenic model of islet cell carcinoma. Cancer Res 55:6071-6076.
100. Parks RR, Yan SD, Huang CC (1993). Tumor necrosis factor-alpha production in head and neck squamous cell carcinoma. Laryngoscope 104:860-864.
101. Penfold CN, Partridge M, Rojas R, Langdon JD (1996). The role of angiogenesis in the spread of oral squamous cell carcinoma. Br J Oral Maxillofac Surg 34:37-41.
102. Petruzelli GJ, Benefield J, Taitz AD, Fowler S, Kalkanis J, Scobercea S, et al. (1997). Heparin-binding growth factor(s) derived from head and neck squamous cell carcinomas induce endothelial cell proliferation. Head & Neck 19:576-582.
103. Pironin M, Clement G, Benzakour O, Barritault D, Lawrence D, Vigier P (1992). Growth in serum-free medium of NIH3T3 cells transformed by the EJ-H-ras oncogene: evidence for multiple autocrine growth factors. Int J Cancer 51:980-988.
104. Rak J, Mitsuhashi Y, Bayko L, Filmus J, Shirasawa S, Sasazuki T, et al. (1995). Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res 55:4575-4580.
105. Rastinejad F, Polverini PJ, Bouck NP (1989). Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 56:345-355.
106. Reiss M, Munoz-Antonia T, Cowan JM, Wilkins PC, Zhou Z, Vellucci VF (1993). Resistance of human squamous cell carcinoma cells to transforming growth factor B1 is a recessive trait. Proc Natl Acad Sci (USA) 90:6280-6284.
107. Risau W (1991). Embryonic angiogenesis factors. Pharmacol & Therap 51:371-376.
108. Rogelj S, Weinberg RA, Fanning P, Klagsbrun M (1988). Basic fibroblast growth factor fused to a signal peptide transforms cells. Nature 331:173-175.
109. Rogers PA, Abberton KM, Susil B (1992). Endothelial cell migratory signal produced by human endometrium during the menstrual cycle. Human Reprod 7:1061-1066.
110. Rudnicka L, Marczak M, Szmurlo A, Makiela B, Skiendzielewska A, Skopinska M, et al. (1991). Acitretin decreases tumor cell-induced angiogenesis. Skin Pharmacol 4:150-153.
111. Ruszcak Z, Detmar M, Imcke E, Orfanos CE (1990). Effects of rIFN alpha, beta and gamma on the morphology, proliferation, and cell surface antigen expression of human dermal microvascular endothelial cell in vitro. J Invest Dermatol 95:693-699.
112. Sacks PG, Harris D, Chou TC (1995). Modulation of growth and proliferation in squamous cell carcinoma by retinoic acid: a rationale for combination therapy with chemotherapeutic agents. Int J Cancer 61:409-415.
113. Saiki I, Sato K, Yoo YC, Murata J, Yoneda J, Kiso M, et al. (1992). Inhibition of tumor-induced angiogenesis by the administration of recombinant interferon-γ followed by a synthetic lipid-A subunit analogue. Int J Cancer 51:641-645.
114. Sakamoto H, Mori M, Taira M, Yoshida T, Matsukawa S, Shimizu K, et al. (1986). Transforming gene from human stomach cancers and a noncancerous portion of the stomach mucosa. Proc Natl Acad Sci USA 83:3997-4001.
115. Sauter ER, Coia LR, Eisenberg BL, Ridge JA (1994). Radiation treatment decreases transforming growth factor alpha expression in squamous cell carcinoma of the tongue. Cancer Lett 78:159-162.
116. Schultz-Hector S, Haghayegh S (1993). B-Fibroblast growth factor expression in human and murine squamous cell carcinomas and its relationship to regional endothelial cell proliferation. Cancer Res 53:1444-1449.
117. Sgadari C, Angiolillo AL, Tosato G (1996). Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10. Blood 87:3877-3882.
118. Shalinsky DR, Bischoff ED, Gregory ML, Gottardis MM, Hayes JS, Lamph WW, et al. (1995). Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude mice. Cancer Res 55:3183-3191.
119. Shklar G, Marefat P, Kornhauser A, Trickler DP, Wallace DK (1980a). Retinoid inhibition of lingual carcinogenesis. Oral Surg 49:325-332.
120. Shklar G, Flynn E, Szabo G, Marefat P (1980b). Retinoid inhibition of experimental lingual carcinogenesis: ultrastructural observations. J Natl Cancer Inst 65:1307-1316.
121. Shklar G, Schwartz J, Grau D, Trickler DP, Wallace DK (1980c). Inhibition of hamster buccal pouch carcinogenesis by 13-cis-retinoic acid. Oral Surg 50:45-53.
122. Sidky Y, Borden E (1987). Inhibition of angiogenesis by interferons: effects on tumor and lymphocyte-induced vascular responses. Cancer Res 47:5155-5161.
123. Singh RK, Gutman M, Bucana CD, Sanchez R, Llansa N, Fidler IJ (1995). Interferons α and β down-regulate the expression of basic fibroblast growth factor in human carcinomas. Proc Natl Acad Sci USA 92:4562-4566.
124. Slaughter DP, Southwick HW, Smejkal W (1953). "Field cancerization" in oral stratified squamous epithelium. Cancer 6:963-968.
125. Smith DR, Polverini PJ, Kunkel SL, Orringer MB, Whyte RI, Burdick MD, et al. (1994). Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma. J Exp Med 179:1409-1415.
126. Soylu L, Ozcan C, Cetik F, Paydas S, Kiroglu M, Aydogan B, et al. (1994). Serum levels of tumor necrosis factor in squamous cell carcinoma of the head and neck. Am J Otolaryngol 15:281-285.
127. Spellman JE, Kulesz-Martin MF, Blumenson LE, Beckett MA, Weichselbaum RR (1995). Clonal interactions in human squamous cell carcinoma. J Surg Res 58:165-174.
128. Sporn MB (1976). Approaches to prevention of epithelial cancer during the preneoplastic period. Cancer Res 36:2699-2702.
129. Stellmach V, Volpert OV, Crawford SE, Lawler J, Hynes RO, Bouck NP (1996). Tumor suppressor genes and angiogenesis: the role of TP53 in fibroblasts. Eur J Cancer 32A:2394-2400.
130. Stricter RM, Kunkel SL, Arenberg DA, Burdick MD, Polverini PJ (1995). Interferon gamma inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis. Biochem Biophys Res Commun 210:51-57.
131. Tanigawa N, Matsumura M, Amaya H, Kitaoka A, Shimomatsuya T, Lu C, et al. (1997).Tumor vascularity correlates with the prognosis of patients with esophageal squamous cell carcinoma. Cancer 79:220-225.
132. Thomas GR, Tubb EE, Sessions RB, Cullen KJ (1993). Growth factor mRNA expression in human head and neck malignant tumors. Arch Otolaryngol Head Neck Surg 119:1247-1252.
133. Todd R, Donoff RB, Wong DT (1997). The molecular biology of oral carcinogenesis: towards a tumor progression model. J Oral Maxillofac Surg 55:612-623.
134. Torry RJ, Rongish BJ (1992). Angiogenesis in the uterus: potential regulation and relation to tumor angiogenesis. Am J Reprod Immun 27:171-179.
135. Twardowski P, Gradishar WJ (1997). Clinical trials of antiangiogenic agents. Curr Opin Oncol 9:584-589.
136. Vasunia KB, Miller ML, Puga A, Baxter CS (1994). Granulocyte-macrophage colony stimulating factor (GM-CSF) is expressed in mouse skin in response to tumor-promoting agents and modulates dermal inflammation and epidermal cells. Carcinogenesis 15:653-660.
137. Vermeulen PB, Gasparini G, Fox SB, Toi M, Martin L, McCulloch P, et al. (1996). Quantification of angiogenesis in solid tumors: an international consensus on the methodology and criteria for evaluation. Eur J Cancer 32(A):2474-2484.
138. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK (1993). Head and neck cancer. N Engl J Med 328:184-194.
139. Volpert OV, Stellmach V, Bouck N (1995). The modulation of thrombospondin and other naturally occurring inhibitors of angiogenesis during tumor progression. Breast Cancer Res Treatment 36:119-126.
140. Volpert OV, Dameron KM, Bouck N (1997). Sequential development of an angiogenic phenotype by human fibroblasts progressing to tumorigenicity. Oncogene 14:1495-1502.
141. Welsh AO, Enders AC (1991). Chorioallantoic placenta formation in the rat: angiogenesis and maternal blood circulation in the mesometrial region of the implantation chamber prior to placenta formation. Am J Anat 192:347-365.
142. Williams JK, Carlson GW, Cohen C, Derose PB, Hunter S, Jurkiewicz MJ (1994). Tumor angiogenesis as a prognostic factor in oral cavity tumors. Am J Surg 168:373-380.
143. Wong DT, Todd R, Tsuji T, Donoff RB (1996). Molecular biology of human oral cancer. Crit Rev Oral Biol Med 7:319-328.
144. Zatterstrom UK, Brun E, Willen R, Kjellen E, Wennerberg J (1995). Tumor angiogenesis and prognosis in squamous cell carcinoma of the head and neck. Head & Neck 17:312-318.
145. Zou CP, Clifford J, Xu XC, Sacks P, Chambon P, Hong WK, et al. (1994). Modulation by retinoic acid of squamous differentiation, cellular RA-binding proteins, and nuclear RA receptors in human head and neck squamous carcinoma cell lines. Cancer Res 54:5479-5487.